{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: United States Pharmaceutical Retailers news", "home_page_url": "https://sharemaestro.com/newsreel/us/healthcare/pharmaceutical-retailers/", "feed_url": "https://sharemaestro.com/newsreel/us/healthcare/pharmaceutical-retailers/feed.json", "description": "Latest Pharmaceutical Retailers company headlines from United States, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:40d7f925eac6f2fe40b73e23a4465e570070c670bc37f641e135ecb073561f69", "url": "https://seekingalpha.com/news/4632786-petmed-express-gaap-eps-of-0_28-misses-by-0_40-revenue-of-41_02m?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4632786-petmed-express-gaap-eps-of-0_28-misses-by-0_40-revenue-of-41_02m?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "PetMed Express GAAP EPS of -$0.28 misses by $0.40, revenue of $41.02M", "content_text": "* PetMed Express press release [https://seekingalpha.com/pr/20619131-petmeds-announces-first-quarter-financial-results] (PETS [https://seekingalpha.com/symbol/PETS]): Q1 GAAP EPS of -$0.28 misses by $0.40. * Revenue of $41.02M (-19.9% Y/Y). MORE ON PETMED EXPRESS * PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4911174-petmed-express-inc-pets-q4-2026-earnings-call-prepared-remarks-transcript] * PetMed Express: High-Risk Turnaround, Hidden Assets, Activism [https://seekingalpha.com/article/4909320-petmed-express-high-risk-turnarou", "date_published": "2026-08-13T20:14:01+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:30ac2e3708f43d20b5a99ed13a328797c84009c62f113906f297860a154b2980", "url": "https://www.stocktitan.net/sec-filings/PETS/form-4-petmed-express-inc-insider-trading-activity-41061ee85529.html", "external_url": "https://www.stocktitan.net/sec-filings/PETS/form-4-petmed-express-inc-insider-trading-activity-41061ee85529.html", "title": "PetMed Express (PETS) grants director Peter Batushansky 55,555 restricted shares", "content_text": "PetMed Express (PETS) director Peter Batushansky was granted 55,555 restricted shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided he continues his service on the Board of Directors, bringing his total direct holdings to 91,928 shares. This grant was reported as an acquisition transaction in a Form 4 filing, indicating director compensation rather than a market purchase.", "date_published": "2026-08-12T20:42:15+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Market update", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:d827300593728609013fc446cf21d9b5b4a873c68a6f85002ecc4c19597a6373", "url": "https://www.stocktitan.net/sec-filings/PETS/form-4-petmed-express-inc-insider-trading-activity-1805d56d482b.html", "external_url": "https://www.stocktitan.net/sec-filings/PETS/form-4-petmed-express-inc-insider-trading-activity-1805d56d482b.html", "title": "PetMed Express (PETS) awards 55,555-share restricted stock grant to director Mennen", "content_text": "PetMed Express (PETS) has awarded director Justin L. Mennen a restricted stock grant of 55,555 shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided Mennen continues his service on the Board of Directors. Following this grant, Mennen directly holds 98,274 shares of PetMed Express common stock.", "date_published": "2026-08-12T20:42:15+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Market update", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:46d914addfa672187fc256e0ffa12256b0acd8dbd1e8741739343335c3453547", "url": "https://www.stocktitan.net/news/SCNX/scienture-announces-commercial-launch-and-fulfillment-of-initial-lz5sepacz3d7.html", "external_url": "https://www.stocktitan.net/news/SCNX/scienture-announces-commercial-launch-and-fulfillment-of-initial-lz5sepacz3d7.html", "title": "Scienture Begins Nationwide Distribution of 10 mg Opioid-Overdose Spray", "content_text": "Scienture (NASDAQ: SCNX) has commercially launched REZENOPY\u2122 (naloxone hydrochloride) Nasal Spray 10 mg, fulfilling initial U.S. wholesaler purchase orders for its second FDA-approved commercial product. This highest-dose naloxone nasal spray is now being distributed nationwide for emergency treatment of opioid overdose, supported by a dedicated sales force and extensive payer coverage. The company aims to penetrate over 60% of the U.S. institutional naloxone market, which is valued at approximately $143 million annually.", "date_published": "2026-08-12T11:39:52+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:1585008690eeae72cfa0048d237525a57597cd2c1060a87ef30d424d0e470c3b", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N44825O:0-petmed-express-inc-expected-to-post-earnings-of-12-cents-a-share-earnings-preview", "external_url": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N44825O:0-petmed-express-inc-expected-to-post-earnings-of-12-cents-a-share-earnings-preview", "title": "PetMed Express, Inc. expected to post earnings of 12 cents a share - Earnings Preview", "content_text": "PetMed Express, Inc. is projected to report earnings of 12 cents per share. This information is presented as an earnings preview from Reuters, indicating an upcoming financial announcement for the company.", "date_published": "2026-08-11T20:40:09+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:01c50f0851c67d8bdf2326ad0356de1e1baab9a46fe44008ecabc4a44728868c", "url": "https://finimize.com/content/pets-asset-snapshot", "external_url": "https://finimize.com/content/pets-asset-snapshot", "title": "PetMed Express Trades Like A Bargain, But Losses Persist", "content_text": "PetMed Express (NASDAQ: PETS), an online pet pharmacy, is experiencing significant losses and declining sales, leading to its stock trading at a deep discount of around $1.96 per share. Despite the low valuation and a recent unsolicited acquisition proposal of $3.00 per share, the company faces substantial risks from competition, negative free cash flow, and execution challenges. The article suggests that while there's potential for upside if operations stabilize or through M&A, the persistent operational issues and high idiosyncratic risk warrant caution for investors.", "date_published": "2026-08-10T01:11:22+00:00", "authors": [{"name": "Finimize"}], "tags": ["Deals and strategy", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:27f53ded364cdb68cc60e019ffc241459c6b000abd21ad4c460d0b259d652ba4", "url": "https://uk.finance.yahoo.com/quote/PETS", "external_url": "https://uk.finance.yahoo.com/quote/PETS", "title": "PetMed Express, Inc. (PETS) Stock Price, News, Quote & History", "content_text": "This Yahoo Finance page provides a comprehensive overview of PetMed Express, Inc. (PETS) stock, including its current price, historical data, financial performance, and analyst insights. The company operates as a pet pharmacy in the United States, offering a range of prescription and non-prescription pet products. Key financial metrics, earnings trends, and valuation measures are presented, along with comparisons to similar companies.", "date_published": "2026-08-08T00:00:57.623165+00:00", "authors": [{"name": "Yahoo! Finance Canada"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:fde43117d9d7517670b12ad4e3c80010c05b3918e51b1e862010ebaf87e8ccae", "url": "https://www.stocktitan.net/sec-filings/WGRX/s-1-wellgistics-health-inc-files-ipo-registration-statement-ee4e404cc0ea.html", "external_url": "https://www.stocktitan.net/sec-filings/WGRX/s-1-wellgistics-health-inc-files-ipo-registration-statement-ee4e404cc0ea.html", "title": "DataMeds AI, Inc. (Nasdaq: MEDS) details 34,462,058-share resale", "content_text": "DataMeds AI, Inc. (Nasdaq: MEDS) has filed an S-1 registration statement detailing the resale of up to 34,462,058 shares of common stock by existing selling stockholders. These shares originate from previously issued stock, convertible notes from May 2026, and various warrants. The company itself will not sell shares or receive proceeds from these resales, but may receive cash from future warrant exercises. The filing highlights potential significant dilution for existing shareholders due to variable conversion prices and low floor prices on convertible instruments.", "date_published": "2026-08-07T22:11:28+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:e977447186de02c1d6e733172b630855273d7c30be5f724f0c997f7c358125aa", "url": "https://www.tradingkey.com/markets/stocks/scnx/news", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/news", "title": "Scienture Holdings Inc (SCNX) Stock News Today", "content_text": "This article provides an overview of Scienture Holdings Inc. (SCNX) stock information, including its current trading price, market cap, and a note about upcoming news. It indicates that more news regarding the company's stock, earnings, and analyst ratings will be available soon.", "date_published": "2026-08-07T20:11:30+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:2668c4df50c987b73254eb1abe4c7051716b49b7d020a3d35a4c78030e9c91d5", "url": "https://www.tradingkey.com/markets/stocks/scnx/forecast", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/forecast", "title": "Scienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "content_text": "The article provides an earnings forecast for Scienture Holdings Inc (SCNX), indicating a current earnings forecast score of 8.00 and a \"Buy\" trend based on one analyst's rating with a target price reflecting a 302.47% upside. It details expected revenue for the next quarter at $1.96M and an anticipated EPS of $-0.18, contrasting with the previous quarter's EPS of $-1.51 against an expectation of $-0.08. The report also includes a peer comparison in the pharmaceuticals industry.", "date_published": "2026-08-07T20:11:30+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:c9b00e95ba1c706b267a4fae753f99d23f8386f679bf94a13356c502e06d2f4f", "url": "https://www.tradingkey.com/markets/stocks/pets/forecast", "external_url": "https://www.tradingkey.com/markets/stocks/pets/forecast", "title": "Petmed Express Inc (PETS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "content_text": "This article provides an earnings forecast for Petmed Express Inc (PETS), detailing its current earnings forecast score, average price target, and analyst rating. It highlights that the company ranks 19th out of 29 in its industry with a \"Sell\" rating from one analyst, and includes historical and projected EPS figures.", "date_published": "2026-08-07T19:09:54+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:91b6677eaa55cb3184ce7898c9d70ad8ec7d8f87c680496285375bb11e0be894", "url": "https://www.tradingview.com/news/tradingview:42611a428f0df:0-pets-q1-26-earnings-revenue-estimate-is-71-00m-usd", "external_url": "https://www.tradingview.com/news/tradingview:42611a428f0df:0-pets-q1-26-earnings-revenue-estimate-is-71-00m-usd", "title": "PETS Q1'26 Earnings: revenue estimate is 71.00M USD", "content_text": "PetMed Express, Inc. (PETS) is expected to release its Q1'26 earnings on August 13, after market close, with an estimated revenue of $71.00 million and EPS of $0.12. The article provides a detailed table comparing historical reported and estimated revenue and EPS figures from Q1'25 to Q1'26, highlighting revenue and EPS surprises.", "date_published": "2026-08-07T07:11:09+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:6f5f898550c2417ebc659f667febd201acbaf9f3144b32703a16a81dc471c286", "url": "https://www.stocktitan.net/sec-filings/WGRX/8-k-wellgistics-health-inc-reports-material-event-81af2e66c349.html", "external_url": "https://www.stocktitan.net/sec-filings/WGRX/8-k-wellgistics-health-inc-reports-material-event-81af2e66c349.html", "title": "DataMEDS AI (WGRX) LOI could give new partners 84.6% ownership stake", "content_text": "DataMEDS AI, Inc. (WGRX) has entered into an Amended and Restated Letter of Intent with several partners to negotiate a stock-based transaction. This potential deal involves acquiring or licensing intellectual property, expanding existing licenses, and obtaining a controlling interest in Tollo Health, LLC. If completed, new investors and partners are expected to collectively hold approximately 84.6% of DataMEDS AI's common stock, significantly reshaping its ownership structure and management.", "date_published": "2026-08-04T23:01:07+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Deals and strategy", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:184ef00fbed491bffbba8419574d0d0f11522ca96aefee34043870481e953d22", "url": "https://kalkine.com.au/company/nasdaq-pets", "external_url": "https://kalkine.com.au/company/nasdaq-pets", "title": "PetMed Express Inc (NASDAQ: PETS) Share Price, PETS Stock News, PETS Share Price & Updates", "content_text": "This article provides detailed financial data and company information for PetMed Express Inc (NASDAQ: PETS), including its stock performance, fundamentals, and recent financial results. It highlights a partnership with Dutch for accessible telehealth services for pets and offers a comprehensive overview of the company's financials, including income statements, balance sheets, and cash flow for several fiscal years. The article also includes a peer comparison within the pharmaceutical retailers sector and a profile of PetMed Express, detailing its operations and key executives.", "date_published": "2026-08-04T10:11:34+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:981e64cc0359a5ec175b455a99459832e7949e62fa5477da35e867b5b0873994", "url": "https://www.manilatimes.net/2026/07/30/tmt-newswire/globenewswire/petmed-express-inc-to-report-first-quarter-fiscal-year-2027-financial-results-on-thursday-august-13-2026/2394989", "external_url": "https://www.manilatimes.net/2026/07/30/tmt-newswire/globenewswire/petmed-express-inc-to-report-first-quarter-fiscal-year-2027-financial-results-on-thursday-august-13-2026/2394989", "title": "PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026", "content_text": "PetMed Express, Inc. (Nasdaq: PETS) announced that it will report its financial results for the first quarter of fiscal year 2027, which ended June 30, 2026, on Thursday, August 13, 2026, after the market closes. The company will also host a conference call and webcast at 4:30 PM Eastern Time on the same day to discuss these results. A telephonic replay of the call will be available until August 27, 2026.", "date_published": "2026-07-31T04:11:34+00:00", "authors": [{"name": "The Manila Times"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:82ff8fd282faf637f108e911e720270e5402fa2eabf88f1f58e53b3889a1de65", "url": "https://pluang.com/en/news-feed/petmed-express-laporan-keuangan-kuartal-pertama-2027", "external_url": "https://pluang.com/en/news-feed/petmed-express-laporan-keuangan-kuartal-pertama-2027", "title": "PetMed Express to announce Q1 FY2027 results on August 13 after market close", "content_text": "PetMed Express will report its first-quarter fiscal year 2027 financial results on August 13, 2026, after the market closes. The online pet pharmacy will host a conference call and webcast at 4:30 PM Eastern Time to discuss these results. A replay of the call will be available until August 27, offering insights into the company's performance in the pet healthcare market.", "date_published": "2026-07-30T20:40:29+00:00", "authors": [{"name": "Pluang"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:349f368f2deccc69b0c678526402b003ae85145ab1d4d72c3dc00ae219885ff2", "url": "https://www.stocktitan.net/news/PETS/pet-med-express-inc-to-report-first-quarter-fiscal-year-2027-6p8laak62zfk.html", "external_url": "https://www.stocktitan.net/news/PETS/pet-med-express-inc-to-report-first-quarter-fiscal-year-2027-6p8laak62zfk.html", "title": "PetMeds sets 4:30 p.m. webcast to review first-quarter results", "content_text": "PetMed Express (NASDAQ: PETS) announced it will release its financial results for the first quarter of fiscal year 2027, covering the period ended June 30, 2026,", "date_published": "2026-07-30T11:39:46+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:42729f6859cf533edca401e765289c4847975aa860f282138372e423ccd30061", "url": "https://www.tradingkey.com/markets/stocks/scnx/stock-analysis", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/stock-analysis", "title": "SCNX|Scienture Holdings Inc|Price:0.355|Chg%:-0.020", "content_text": "This article provides a detailed stock analysis of Scienture Holdings Inc (SCNX), highlighting its healthy fundamentals, significant growth potential, and fair valuation within the Pharmaceuticals industry. The company, focused on developing treatments for central nervous system and cardiovascular diseases, is currently in a growing phase with high profit growth. Despite an average market performance, analysts maintain a \"Buy\" rating with a target price indicating substantial upside.", "date_published": "2026-07-30T07:41:30+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:0764786ac1311af51d867ecd91c64546bb4890878482749d98c4221ed3430191", "url": "https://www.tradingkey.com/markets/stocks/pets/sentiment", "external_url": "https://www.tradingkey.com/markets/stocks/pets/sentiment", "title": "Petmed Express Inc (PETS) Institutional Confidence", "content_text": "This article analyzes the institutional confidence in Petmed Express Inc (PETS), showing its current institutional shareholding score and ranking within the Food & Drug Retailing industry. It details the latest institutional shareholding proportion, the largest institutional shareholder (James Simons), and a list of key institutional shareholders along with their shareholdings and changes. The data indicates a quarter-over-quarter increase in institutional shareholding proportion.", "date_published": "2026-07-30T07:39:46+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:a2a3a0d22c05edeb40b5cdbc354599ef773429f751d9f3ec9e27fe1c1118954f", "url": "https://www.tradingkey.com/markets/stocks/scnx/financial-health", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/financial-health", "title": "Scienture Holdings Inc (SCNX) Financial Health: Profitability & Balance Sheet Analysis", "content_text": "Scienture Holdings Inc (SCNX) currently holds a financial score of 6.05, placing it 145th out of 155 in the Pharmaceuticals industry, indicating robust financial health but low operating efficiency. The company recently reported a significant year-over-year revenue increase of 449.08% to 56.33K and an 11.04% rise in net profit. However, specific financial metrics for quality of earnings, operational efficiency, growth potential, and shareholder returns are not yet disclosed by the company.", "date_published": "2026-07-30T06:41:30+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:d4245a374eb809e6fde4d64c13dac73ac1240d4b4abe599845fe01d23b5659c1", "url": "https://www.tradingkey.com/markets/stocks/scnx/technical", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/technical", "title": "Scienture Holdings Inc (SCNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "content_text": "This article provides a technical analysis of Scienture Holdings Inc (SCNX), detailing its stock price momentum, support and resistance levels, and various technical indicators and moving averages. As of July 29, 2026, SCNX has a price momentum score of 5.32, with the stock trading between a resistance of $0.43 and a support of $0.30. Technical indicators show a mixed signal, with several \"Sell\" recommendations based on MACD, KDJ, Williams %R, TRIX, and all moving averages, while RSI and CCI are neutral and StochRSI is oversold.", "date_published": "2026-07-30T02:50:28+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:d507aa4bf9c63d7e8a5410f9e5f3d50f8f01239a277bd37758e9668c4bcab163", "url": "https://www.tradingview.com/symbols/LSX-121843/financials-segments", "external_url": "https://www.tradingview.com/symbols/LSX-121843/financials-segments", "title": "PetMed Express, Inc. Revenue Breakdown \u2013 LSX:121843", "content_text": "PetMed Express, Inc. (LSX:121843) generated \u20ac154.95 million in revenue last year, with its Reorder segment contributing the most at \u20ac127.91 million. The United States was the primary regional contributor, accounting for all reported revenue. This indicates a focus on the U.S. market and recurring revenue streams through reorders.", "date_published": "2026-07-29T14:39:46+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:c8918eec5f39f1d8159735966f8e04cbf58c525f2915d93600a319f9d809bea4", "url": "https://www.webull.com/news/15298818304386048", "external_url": "https://www.webull.com/news/15298818304386048", "title": "When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable?", "content_text": "Scienture Holdings, Inc. (NASDAQ:SCNX) is a pharmaceutical company that has expanded its losses, reporting a US$42m loss recently. Analysts predict the company could reach profitability by 2028, with an expected profit of US$9.0m, requiring an aggressive average annual growth rate of 71%. The company distinguishes itself by having no debt, which lessens investment risk despite its current cash-burning operations.", "date_published": "2026-07-29T07:50:28+00:00", "authors": [{"name": "Webull"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:c1f2f668136da8f4552700593c4f08524ff80505b9396b783e956645d8887b31", "url": "https://www.tradingkey.com/markets/stocks/scnx/risk-assesment", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/risk-assesment", "title": "Scienture Holdings Inc (SCNX) Risk Assessment: Volatility, Financial Risk & Investment Risk", "content_text": "This article provides a risk assessment for Scienture Holdings Inc (SCNX), highlighting its volatility and financial risks. SCNX has a beta value of 3.25, indicating high sensitivity to market movements, and a low risk assessment score within the Pharmaceuticals industry. The report details various metrics including VaR, maximum drawdown, volatility, and Sharpe Ratios over different periods, offering insights into the stock's performance and liquidity.", "date_published": "2026-07-29T02:10:27+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Market update", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:456193b8ae3391567426fff755ca7acbff5bba7adf9869aa1ba5aeb35e0e0f15", "url": "https://www.democratandchronicle.com/press-release/story/23056/wellgistics-health-terminates-equity-line-of-credit-to-further-support-growth-strategy", "external_url": "https://www.democratandchronicle.com/press-release/story/23056/wellgistics-health-terminates-equity-line-of-credit-to-further-support-growth-strategy", "title": "Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy", "content_text": "Wellgistics Health Inc. (NASDAQ:WGRX) has announced the termination of its equity purchase agreement with Hudson Global Ventures, LLC, a strategic move to shift towards accretive financing and reinforce long-term shareholder value. The decision was driven by strong execution in expanding its pharmacy network and accelerating AI-powered prescription routing technology adoption. The company aims to optimize its capital structure and pursue more favorable funding opportunities to support its growth trajectory and focus on operational strength.", "date_published": "2026-07-28T19:41:18+00:00", "authors": [{"name": "Democrat and Chronicle"}], "tags": ["Earnings", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:b55e6f90a274bdf5b2bcd3fba5e040ec540d6fa95fee720f35088bfbf8a16042", "url": "https://www.tradingview.com/symbols/NASDAQ-SCNX/financials-segments", "external_url": "https://www.tradingview.com/symbols/NASDAQ-SCNX/financials-segments", "title": "Scienture Holdings, Inc. Revenue Breakdown \u2013 NASDAQ:SCNX", "content_text": "Scienture Holdings, Inc. (NASDAQ:SCNX) generated $431.61K USD in revenue last year, primarily from its Products for the Treatment of Cardiovascular and Central Nervous System Diseases segment. The United States was the leading contributor, accounting for the entire $431.61K USD in revenue, an increase from $136.64K USD the previous year.", "date_published": "2026-07-28T11:41:11+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:780fe5161d2be80f54e6607ae0b02db2081b8054d38c373d9ccaa49b00ef4811", "url": "https://www.tradingkey.com/markets/stocks/scnx/cash-flow", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/cash-flow", "title": "Scienture Holdings Inc (SCNX) Cash Flow", "content_text": "This article provides the quarterly and annual cash flow statements for Scienture Holdings Inc (SCNX), allowing users to assess the company's financial health. It details operating, investing, and financing cash flows, along with related metrics like net income from continuing operations and free cash flow. The data highlights various financial figures and their year-over-year changes, complemented by an FAQ section explaining key cash flow concepts.", "date_published": "2026-07-28T03:41:28+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:ebe224dbee578f8ce40fe82e5d5929bb5684fe5eb6585af65276d0b9b5ee7bf1", "url": "https://www.tradingkey.com/markets/stocks/pets/dividend-splits", "external_url": "https://www.tradingkey.com/markets/stocks/pets/dividend-splits", "title": "Petmed Express Inc (PETS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "content_text": "This article provides a historical overview of Petmed Express Inc (PETS) dividends and stock splits. It details cash dividend payouts from May 2021 to August 2023, specifying the dividend amount, record date, payment date, and ex-dividend date for each. The data indicates that PETS has consistently distributed a gross dividend of USD 0.3 per share over this period.", "date_published": "2026-07-27T05:11:22+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:b5e040dcae489a41bff63aaa7bd1eba6ca5dce112cd3070ec1c173376cb68568", "url": "https://www.tradingkey.com/markets/stocks/pets/revenue", "external_url": "https://www.tradingkey.com/markets/stocks/pets/revenue", "title": "Petmed Express Inc (PETS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "content_text": "This article provides a revenue breakdown for Petmed Express Inc (PETS), focusing on its business segments. Key revenue contributions for FY2026Q3 show that reorder sales account for the vast majority (83.67%) of revenue, followed by new order sales (12.37%), and membership fees (3.96%). Regional revenue and profit contribution data are not yet disclosed by the company.", "date_published": "2026-07-27T05:11:22+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:b041c9af7ad6c8f280af117172104d03a754fff753f31636a7334b6541976810", "url": "https://www.tradingkey.com/markets/stocks/scnx/dividend-splits", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/dividend-splits", "title": "Scienture Holdings Inc (SCNX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "content_text": "This article provides a historical overview of dividend payouts and stock splits for Scienture Holdings Inc (SCNX). It notes that the company has distributed $0.00 in dividends over the past five years and details multiple 15-to-1 merger-related stock splits on June 21, 2023. The information is presented by TradingKey, offering a quick look into SCNX's capital distribution history.", "date_published": "2026-07-27T04:39:35+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Deals and strategy", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:49dc181e6df750d5977c62c02b1aacdb3e1ee706c9683e53c5c463ea38ec410d", "url": "https://www.moomoo.com/news/post/73296735/wellgistics-health-inc-officially-changes-corporate-name-to-datameds-ai", "external_url": "https://www.moomoo.com/news/post/73296735/wellgistics-health-inc-officially-changes-corporate-name-to-datameds-ai", "title": "WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.", "content_text": "Wellgistics Health, Inc. has officially changed its corporate name to DataMeds AI, Inc. This rebranding reflects the company's strategic shift towards integrating artificial intelligence and advanced data analytics into its healthcare solutions. The new name emphasizes its commitment to leveraging technology for innovative medical data management and analysis.", "date_published": "2026-07-25T18:40:01+00:00", "authors": [{"name": "Moomoo"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:b50d50eabea715a1e5ffbcc8cd7d3a83f939343d9e07f3df1e93e81ed29cd67c", "url": "https://www.tradingkey.com/markets/stocks/pets", "external_url": "https://www.tradingkey.com/markets/stocks/pets", "title": "PETS|Petmed Express Inc|Price:1.990|Chg%:-0.060", "content_text": "Petmed Express Inc (PETS) closed at $1.99, down 2.93% on July 24, 2026. The company, a direct-to-consumer pet pharmacy, shows strong fundamentals and high growth potential but is considered fairly valued with analysts rating it as \"Sell.\" Its stock price is expected to trend down in the medium term, trading sideways between support and resistance levels.", "date_published": "2026-07-25T08:14:07+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:64c9453afab61d5563fe362d323d5ee9ef96baebc5d373fd1521fbb441ca9c3b", "url": "https://www.tradingkey.com/markets/stocks/scnx/company", "external_url": "https://www.tradingkey.com/markets/stocks/scnx/company", "title": "SCNX|Scienture Holdings Inc|Price:0.374|Chg%:-0.017", "content_text": "Scienture Holdings Inc. (SCNX) is a specialty pharmaceutical company focused on developing products for central nervous system and cardiovascular diseases. The company is developing several product candidates, including treatments for hypertension, migraine, pain, and thrombosis. Key executives and institutional shareholding information are also provided, showing a significant increase in institutional ownership.", "date_published": "2026-07-25T03:42:25+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "SCNX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SCNX", "name": "Scienture Holdings, Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/19261884-00bf-4398-a64d-0a7ee4db03f6/"}]}}, {"id": "source:c91ea011e34fdef8b8929c49b877e074db635ca52f908da4df8458843cf278a7", "url": "https://www.stocktitan.net/sec-filings/PETS/form-4-a-petmed-express-inc-amended-insider-trading-activity-205f611d87b1.html", "external_url": "https://www.stocktitan.net/sec-filings/PETS/form-4-a-petmed-express-inc-amended-insider-trading-activity-205f611d87b1.html", "title": "PetMed Express (NASDAQ: PETS) awards stock and PSUs to interim CFO", "content_text": "PetMed Express (NASDAQ: PETS) has awarded interim CFO Douglas Krulik 32,500 restricted common shares and 32,500 performance share units (PSUs). The restricted shares vest 50% on June 26, 2027, and 50% on June 26, 2028, contingent on continued employment. The PSUs are tied to the company's total shareholder return relative to the S&P 600 Specialty Retail Index from April 1, 2026, to March 31, 2028.", "date_published": "2026-07-24T20:11:12+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Market update", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:fa530b37b7498a25c8812e6f5961b70f9e742c608b648882d40095b40d230d76", "url": "https://www.marketscreener.com/quote/stock/DATAMEDS-AI-INC-182307522/news/Wellgistics-Health-Selects-Top-Five-Blockchain-Platforms-to-Initiate-Patent-Protected-PharmacyChain-52611567", "external_url": "https://www.marketscreener.com/quote/stock/DATAMEDS-AI-INC-182307522/news/Wellgistics-Health-Selects-Top-Five-Blockchain-Platforms-to-Initiate-Patent-Protected-PharmacyChain-52611567", "title": "Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate", "content_text": "Wellgistics Health, Inc. has chosen Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu, and Corda (R3) as the top five blockchain platforms to develop its patent-protected PharmacyChain\u2122 system. This system will utilize smart contracts to track pharmaceutical drugs, supporting industry-wide serialization mandates like the DSCSA. The company aims to integrate this technology within its own pharmacy by the end of Q2 2026 and eventually offer it to its network of over 6,500 independent pharmacies and other major industry participants, leveraging its intellectual property to improve pharmaceutical supply chain management and transparency.", "date_published": "2026-07-24T17:40:12+00:00", "authors": [{"name": "www.marketscreener.com"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:5b3b3f45f1ef37b0a2b50ebd4ffb27c0c4343f37d9340653770bbd1310f45fc9", "url": "https://au.finance.yahoo.com/quote/PETS", "external_url": "https://au.finance.yahoo.com/quote/PETS", "title": "PetMed Express, Inc. (PETS) stock price, news, quote and history", "content_text": "PetMed Express, Inc. (PETS) stock closed at $1.99, down 2.93% on July 24, 2026, with an after-hours price of $1.9013. The company, a pet pharmacy providing prescription and non-prescription medications and supplies, has seen significant negative returns over the past year and five years, but its YTD return is -37.81%. Analysts have an average price target of $2.15 to $3.2 for PETS, with Morgan Stanley maintaining an Underweight rating.", "date_published": "2026-07-24T13:14:07+00:00", "authors": [{"name": "Market source"}], "tags": ["Analyst action", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:ab27324bdd81abe13c3441f9f15b33d311ae2e7307aeeb282352a20b9624ad02", "url": "https://marketingreport.one/pr/rpr-secures-wellgistics-health-comms-brief.html", "external_url": "https://marketingreport.one/pr/rpr-secures-wellgistics-health-comms-brief.html", "title": "RPR secures Wellgistics Health comms brief", "content_text": "Rubenstein Public Relations (RPR) has been appointed as the agency of record for Wellgistics Health, Inc., a health technology company listed on NASDAQ under WGRX. RPR will lead a communications campaign focusing on thought leadership, corporate positioning, and promoting Wellgistics Health's AI-integrated healthcare ecosystem and licensed technologies. Wellgistics Health, known for its EinsteinRx AI platform, is developing \"Health Lives Here\" mobile app to consolidate patient health data and improve access to care.", "date_published": "2026-07-24T09:09:45+00:00", "authors": [{"name": "https://marketingreport.one/"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:810b7504b5b9622cbd0aa6aeff1777c539f2041cfe717adc59c8f2da839a8370", "url": "https://simplywall.st/stock/nasdaqcm/meds", "external_url": "https://simplywall.st/stock/nasdaqcm/meds", "title": "DataMEDS AI (NasdaqCM:MEDS) Stock Price", "content_text": "DataMEDS AI (formerly Wellgistics Health, Inc.) operates as a health IT company developing AI-powered tools for healthcare, including pharmacy dispensing and patient adherence solutions. The company recently changed its name and appointed Brett Thompson as its new CTO. DataMEDS AI is currently facing Nasdaq delisting deficiency warnings due to insufficient stockholders' equity and is working to regain compliance through strategic acquisitions and a proposed merger to create DelivMeds AI.", "date_published": "2026-07-23T14:40:44+00:00", "authors": [{"name": "Simply Wall Street"}], "tags": ["Deals and strategy", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:6dec3b39688cfcb9aae0a8b8427282b5ba00a7c87c176dd3e4bb2c6afb26b904", "url": "https://www.tradingview.com/news/tradingview:b244da4be10f6:0-petmed-express-to-sell-delray-beach-headquarters-for-37-million-in-sale-leaseback-with-redfearn", "external_url": "https://www.tradingview.com/news/tradingview:b244da4be10f6:0-petmed-express-to-sell-delray-beach-headquarters-for-37-million-in-sale-leaseback-with-redfearn", "title": "PetMed Express To Sell Delray Beach Headquarters For $37 Million In Sale-Leaseback With Redfearn", "content_text": "PetMed Express is selling its Delray Beach headquarters for $37 million in a sale-leaseback agreement with Redfearn Capital Acquisitions. The deal involves leasing back the 100,519-square-foot property for an initial 10-year term, with options for extension. This move aims to monetize real estate assets and enhance the company's liquidity.", "date_published": "2026-07-23T13:39:42+00:00", "authors": [{"name": "TradingView"}], "tags": ["Deals and strategy", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:360bf989d0055f4463b85081092d50a23ba3cb2f59e8278a873f7fd777e93be3", "url": "https://www.manilatimes.net/2026/07/23/tmt-newswire/globenewswire/petmeds-announces-proposed-sale-leaseback-of-headquarters-and-distribution-center-buildings-for-37-million/2390237/amp", "external_url": "https://www.manilatimes.net/2026/07/23/tmt-newswire/globenewswire/petmeds-announces-proposed-sale-leaseback-of-headquarters-and-distribution-center-buildings-for-37-million/2390237/amp", "title": "PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million", "content_text": "PetMed Express, Inc. (Nasdaq: PETS) has entered into a definitive agreement for a sale-leaseback transaction of its headquarters and distribution center buildings in Delray Beach, FL, for an aggregate purchase price of $37 million. This move aims to strengthen the company's balance sheet, optimize its asset base, and provide financial flexibility for future investments. PetMeds expects to close the transaction within the next 120 days, continuing to occupy the premises.", "date_published": "2026-07-23T12:39:42+00:00", "authors": [{"name": "The Manila Times"}], "tags": ["Market update", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:af3f75e308474bdc602c1952550cb2523c589f201c8831b5fab5b6d0b43fc381", "url": "https://www.gurufocus.com/news/8974446/petmed-express-pets-executes-37-million-saleleaseback-deal", "external_url": "https://www.gurufocus.com/news/8974446/petmed-express-pets-executes-37-million-saleleaseback-deal", "title": "PetMed Express (PETS) Executes $37 Million Sale-Leaseback Deal", "content_text": "PetMed Express (PETS) has finalized a $37 million sale-leaseback agreement for its headquarters and distribution facilities in Delray Beach, Florida. This strategic move aims to unlock capital and improve liquidity, with the transaction expected to close within four months. Despite facing financial challenges, reflected by negative earnings and a low GF Score\u2122 of 56, insider buying activity suggests confidence in the company's future.", "date_published": "2026-07-23T12:39:42+00:00", "authors": [{"name": "GuruFocus"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:3f46ff4cb296118c5ebc5d9a1788ff4616172b4c7053a07b78908d7a551f5c48", "url": "https://www.stocktitan.net/news/PETS/pet-meds-announces-proposed-sale-leaseback-of-headquarters-and-cekt3ceuikpu.html", "external_url": "https://www.stocktitan.net/news/PETS/pet-meds-announces-proposed-sale-leaseback-of-headquarters-and-cekt3ceuikpu.html", "title": "PetMeds' $37M property deal would keep its Florida offices", "content_text": "PetMed Express (NASDAQ: PETS) announced a definitive agreement for a $37 million sale-leaseback transaction involving its headquarters and distribution center in Delray Beach, Florida. This move aims to strengthen its balance sheet, optimize assets, and unlock real estate value, while allowing the company to continue occupying its current facilities. The closing is anticipated within 120 days, subject to due diligence and the finalization of leaseback terms.", "date_published": "2026-07-23T11:39:42+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Earnings", "PETS"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PETS", "name": "PetMed Express Inc", "sentiment_url": "https://sharemaestro.com/sentiment/2f5dd2f8-3f6b-47c2-97d0-040060fb8fd5/"}]}}, {"id": "source:b1a80918b15fbc621dfcbc96d401f98540a71e379f73d29590a5f259ddd1ad62", "url": "https://uk.finance.yahoo.com/quote/WGRX", "external_url": "https://uk.finance.yahoo.com/quote/WGRX", "title": "DataMEDS AI, Inc. (WGRX) stock price, news, quote and history", "content_text": "This Yahoo Finance page provides a comprehensive overview of DataMEDS AI, Inc. (WGRX), detailing its stock price, company information, key financial statistics, and performance metrics. It notes a recent ticker change to MEDS effective July 22, 2026, and highlights the company's significant negative returns over various periods, despite a positive year-to-date return of 82.38%. The article also describes DataMEDS AI, Inc.'s operations in pharmaceutical wholesale and distribution.", "date_published": "2026-07-22T16:09:45+00:00", "authors": [{"name": "Market source"}], "tags": ["Earnings", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:df2779df1943af4bb9b40a26f272671c2a0cc7b42112829144019cde4dfdc61d", "url": "https://www.bitget.com/amp/news/detail/12560605526270", "external_url": "https://www.bitget.com/amp/news/detail/12560605526270", "title": "Wellgistics Health changes name to DataMEDS AI, adopts Nasdaq ticker MEDS", "content_text": "Wellgistics Health has officially changed its corporate name to DataMEDS AI, Inc., with its NASDAQ ticker symbol set to switch from WGRX to MEDS on July 22, 2026. This rebranding reflects the company's strategic decision to expand its AI pharmacy platform into a broader digital health market, leveraging its proprietary blockchain infrastructure. The announcement was originally published on EDGAR by Wellgistics Health Inc.", "date_published": "2026-07-22T03:13:13+00:00", "authors": [{"name": "Bitget"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:2cc15784b2013ab6fac1bd35bd885578bedaa095f6cc22533b5be7cc0f3bd615", "url": "https://www.benzinga.com/trading-ideas/movers/26/07/60587584/12-health-care-stocks-moving-tuesday-s-intraday-session", "external_url": "https://www.benzinga.com/trading-ideas/movers/26/07/60587584/12-health-care-stocks-moving-tuesday-s-intraday-session", "title": "12 Health Care Stocks Moving In Tuesday's Intraday Session", "content_text": "This article lists 12 healthcare stocks experiencing significant price movements during Tuesday's intraday session, identifying both gainers and losers. China Pharma Holding (CPHI) saw the largest increase, while Zhengye Biotechnology (ZYBT) experienced the steepest decline. The report provides each company's stock symbol, percentage change, and market capitalization.", "date_published": "2026-07-21T17:09:37+00:00", "authors": [{"name": "Benzinga"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:f80dd5b73363115aea7487501ace65d14b6cde817e7ce0ea973abb5c7f514871", "url": "https://www.moomoo.com/news/post/73296684/wellgistics-health-announces-it-has-officially-completed-its-name-change", "external_url": "https://www.moomoo.com/news/post/73296684/wellgistics-health-announces-it-has-officially-completed-its-name-change", "title": "Wellgistics Health Announces It Has Officially Completed Its Name Change to DataMEDS AI", "content_text": "Wellgistics Health has officially changed its name to DataMEDS AI, marking a strategic shift towards leveraging AI, machine learning, and advanced data analytics in healthcare. The company aims to enhance its digital pharmacy services and improve patient outcomes through data-driven solutions. This rebranding reflects its commitment to innovating healthcare intelligence.", "date_published": "2026-07-21T16:09:45+00:00", "authors": [{"name": "Moomoo"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:6b93c3a25a78c101389e4bfa76c19787c9b5e57715259834aafd2c526b83938f", "url": "https://www.bizjournals.com/tampabay/news/2026/07/21/welligistics-tampa-turnaround.html", "external_url": "https://www.bizjournals.com/tampabay/news/2026/07/21/welligistics-tampa-turnaround.html", "title": "Wellgistics Health caps turnaround with rebrand to become DataMEDS AI", "content_text": "Wellgistics Health, after narrowly avoiding Nasdaq delisting, has rebranded as DataMEDS AI following a restructuring, new leadership, and financing. The company's new focus is on patient-owned health data, aiming to empower individuals to control their medical information. This rebrand marks a significant chapter in the company's turnaround efforts.", "date_published": "2026-07-21T16:09:37+00:00", "authors": [{"name": "The Business Journals"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:dd55a2aa028fe25555f70150fc4409554d166c7c6cfc4d97ca38b62c7b30ab43", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-wgrx/datameds-ai", "external_url": "https://simplywall.st/stocks/us/healthcare/nasdaq-wgrx/datameds-ai", "title": "DataMEDS AI (Nasdaq:WGRX) - Stock Analysis", "content_text": "This article provides a detailed stock analysis of DataMEDS AI (Nasdaq:MEDS/WGRX), highlighting its current financial status, market performance, and recent corporate developments. It covers concerns like negative shareholders' equity, declining earnings, and delisting notices from Nasdaq, alongside strategic initiatives such as planned acquisitions and a change in CTO. The analysis also points out the company's high share price volatility and low market capitalization as major risks.", "date_published": "2026-07-21T15:39:51+00:00", "authors": [{"name": "Simply Wall Street"}], "tags": ["Deals and strategy", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:3ca0817bd79c791aecb810dc7633022b49f59027d4340c19cc28b1b2de35ca19", "url": "https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/wellgistics-health-announces-updated-record-date-for-distribution-of-1193339", "external_url": "https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/wellgistics-health-announces-updated-record-date-for-distribution-of-1193339", "title": "Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders", "content_text": "Wellgistics Health has announced an updated record date of July 31, 2026, for the distribution of the Dream Bowl 2026 Meme Coin to its stockholders. Each share of Wellgistics common stock held on this new record date will entitle the holder to fifty Dream Bowl 2026 Meme Coins. This follows an earlier announcement in December 2025 regarding the distribution, with detailed instructions for obtaining digital wallet information to be provided to stockholders.", "date_published": "2026-07-20T13:36:46+00:00", "authors": [{"name": "ACCESS Newswire"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}, {"id": "source:2a15bc52a945f785242ce6162c42de1843c3eab6318b11f0e6ee471c8c186d97", "url": "https://www.stocktitan.net/news/DVLT/wellgistics-health-announces-updated-record-date-for-distribution-of-8rzq9rw9iglq.html", "external_url": "https://www.stocktitan.net/news/DVLT/wellgistics-health-announces-updated-record-date-for-distribution-of-8rzq9rw9iglq.html", "title": "Wellgistics Says July 31 Holders Are Entitled to 50 Dream Bowl Coins", "content_text": "Wellgistics Health has updated the record date for its Dream Bowl 2026 Meme Coin distribution to July 31, 2026. Stockholders as of this date will receive 50 Meme Coins per share, a significant increase from the previously announced one-per-share. The company emphasized that the Meme Coins are solely for entertainment and event access, carrying no investment or monetary rights, and the actual distribution date is yet to be determined in coordination with Datavault AI.", "date_published": "2026-07-20T13:24:46+00:00", "authors": [{"name": "Stock Titan"}], "tags": ["Market update", "WGRX"], "_sharemaestro": {"country": "United States", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WGRX", "name": "Wellgistics Health, Inc. Common Stock", "sentiment_url": "https://sharemaestro.com/sentiment/cb21bd47-bccc-4fc1-8c18-c25523350a43/"}]}}]}